Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 4 6Phase 3 5Phase 2 4Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 22Breast Neoplasms 21Polycystic Ovary Syndrome 12Carcinoma, Non-Small-Cell Lung 11Colorectal Neoplasms 10Lung Neoplasms 8Endometrial Neoplasms 7Pancreatic Neoplasms 6Neoplasms 6Glioblastoma 5Rectal Neoplasms 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Insulin Resistance 4Adenocarcinoma of Lung 4Adenocarcinoma 4Uterine Cervical Neoplasms 3Leukoplakia, Oral 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Obesity 2Neoplasm Metastasis 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Hyperandrogenism 2Esophageal Neoplasms 2Erythroplasia 2Endometrial Hyperplasia 2Diabetes Mellitus 2Colonic Neoplasms 2

Interventions

Metformin 4Inositol 2salicylsalicylic acid 1maltodextrin 1licogliflozin 1Tooth Exfoliation 1Sodium Salicylate 1Root Planing 1Pioglitazone 1Inulin 1Exercise 1Exenatide 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Insulin Resistance × Metformin × Clear all
NCT05306028 2025-02-21

Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c)

Fudan University

Phase 2 Active not recruiting
20 enrolled

Diabetes Mellitus, Insulin Resistance

NCT02647827 2024-10-09

PIAII

Karolinska Institutet

Phase 2 Recruiting
303 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01340300 2018-06-06

Exercise and Metformin in Colorectal and Breast Cancer Survivors

Dana-Farber Cancer Institute

Phase 2 Completed
139 enrolled 18 charts
BreastGastrointestinal

Breast Neoplasms, Insulin Resistance, Motor Activity, Colorectal Neoplasms

NCT00344851 2007-07-11

Exenatide and Metformin Therapy in Overweight Women With PCOS

Metabolic Center of Louisiana Research Foundation

Phase 2 Completed
60 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡